Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intragastric pH and Bismuth Effect for H. Pylori Eradication
NCT02894892Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bismuth subsalicylate in Helicobacter pylori infection (7 arms), sponsored by National Taiwan University Hospital. Primary endpoint: The morphological changes of post-drug H. pylori by electron microscopy at 3 years. Started Nov 2016; status: completed.
02
Drugs
bismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02894892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894892.